Menu Search
Equities

Novartis AG

NOVN:SWX

Novartis AG

Actions
  • Price (CHF)91.56
  • Today's Change0.57 / 0.63%
  • Shares traded3.33m
  • 1 Year change+7.63%
  • Beta0.9344
Data delayed at least 15 minutes, as of Nov 21 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 20-Nov-24
Select bar for recommendation details.
Recommendations20-Nov-24
Buy3
Outperform4
Hold14
Sell2
Strong Sell0

Share price forecast in USD

The 19 analysts offering 12 month price targets for Novartis AG have a median target of 105.03, with a high estimate of 124.04 and a low estimate of 85.02. The median estimate represents a 14.72% increase from the last price of 91.56.
High35.5%124.04
Med14.7%105.03
Low-7.1%85.02

Dividends in USD

In 2023, Novartis AG reported a dividend of 3.92 USD, which represents a 13.28% increase over last year. The 16 analysts covering the company expect dividends of 3.74 USD for the upcoming fiscal year, a decrease of 4.55%.
Div growth (TTM)13.28%
More ▼

Earnings history & estimates in USD

On Oct 29, 2024, Novartis AG reported 3rd quarter 2024 earnings of 2.06 per share. This result exceeded the 1.95 consensus of the 9 analysts covering the company and exceeded last year's 3rd quarter results by 12.57%.
The next earnings announcement is expected on Jan 31, 2025.
Average growth rate+3.82%
Novartis AG reported annual 2023 earnings of 6.90 per share on Jan 31, 2024.
Average growth rate+6.48%
More ▼

Revenue history & estimates in USD

Novartis AG had 3rd quarter 2024 revenues of 12.82bn. This bettered the 12.74bn consensus of the 10 analysts covering the company. This was 1.00% below the prior year's 3rd quarter results.
Average growth rate+2.19%
Novartis AG had revenues for the full year 2023 of 45.44bn. This was 10.10% below the prior year's results.
Average growth rate-0.88%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.